Literature DB >> 23810240

Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells.

Tatsuya Oka1, Eon J Rios, Mindy Tsai, Janet Kalesnikoff, Stephen J Galli.   

Abstract

BACKGROUND: Rapid desensitization transiently prevents severe allergic reactions, allowing administration of life-saving therapies in previously sensitized patients. However, the mechanisms underlying successful rapid desensitization are not fully understood.
OBJECTIVES: We sought to investigate whether the mast cell (MC) is an important target of rapid desensitization in mice sensitized to exhibit IgE-dependent passive systemic anaphylaxis in vivo and to investigate the antigen specificity and underlying mechanisms of rapid desensitization in our mouse model.
METHODS: C57BL/6 mice (in vivo) or primary isolated C57BL/6 mouse peritoneal mast cells (PMCs; in vitro) were passively sensitized with antigen-specific anti-2,4-dinitrophenyl IgE, anti-ovalbumin IgE, or both. MCs were exposed over a short period of time to increasing amounts of antigen (2,4-dinitrophenyl-human serum albumin or ovalbumin) in the presence of extracellular calcium in vitro or by means of intravenous administration to sensitized mice in vivo before challenging the mice with or exposing the PMCs to optimal amounts of specific or irrelevant antigen.
RESULTS: Rapidly exposing mice or PMCs to progressively increasing amounts of specific antigen inhibited the development of antigen-induced hypothermia in sensitized mice in vivo and inhibited antigen-induced PMC degranulation and prostaglandin D2 synthesis in vitro. Such MC hyporesponsiveness was induced antigen-specifically and was associated with a significant reduction in antigen-specific IgE levels on MC surfaces.
CONCLUSIONS: Rapidly exposing MCs to progressively increasing amounts of antigen can both enhance the internalization of antigen-specific IgE on the MC surface and also desensitize these cells in an antigen-specific manner in vivo and in vitro.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  2,4-Dinitrophenyl; Anaphylaxis; BMCMC; Bone marrow–derived cultured mast cell; DNP; FITC; Fluorescein isothiocyanate; HSA; Human serum albumin; IgE; MC; MCPT-1; MFI; Mast cell; Mast cell protease 1; Mean fluorescence intensity; OVA; Ovalbumin; PGD(2); PMC; PSA; Passive systemic anaphylaxis; Peritoneal mast cell; Prostaglandin D(2); STAT6; Signal transducer and activator of transcription 6; antigen; basophil; degranulation; desensitization; mast cell; rapid desensitization; receptor internalization; rush desensitization

Mesh:

Substances:

Year:  2013        PMID: 23810240      PMCID: PMC3789647          DOI: 10.1016/j.jaci.2013.05.004

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  38 in total

1.  Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy.

Authors:  Halina Plewako; Katarzyna Wosińska; Monica Arvidsson; Janne Bjorkander; Per Stahl Skov; Lena Håkansson; Sabina Rak
Journal:  Int Arch Allergy Immunol       Date:  2006-08-29       Impact factor: 2.749

2.  Egg oral immunotherapy in nonanaphylactic children with egg allergy.

Authors:  Ariana D Buchanan; Todd D Green; Stacie M Jones; Amy M Scurlock; Lynn Christie; Karen A Althage; Pamela H Steele; Laurent Pons; Rick M Helm; Laurie A Lee; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2006-10-27       Impact factor: 10.793

3.  Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization.

Authors:  Maria del Carmen Sancho-Serra; Maria Simarro; Mariana Castells
Journal:  Eur J Immunol       Date:  2011-03-01       Impact factor: 5.532

4.  Diagnosis and management of drug hypersensitivity reactions.

Authors:  Antonino Romano; Maria J Torres; Mariana Castells; Maria L Sanz; Miguel Blanca
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

Review 5.  Anaphylaxis: acute treatment and management.

Authors:  Johannes Ring; Martine Grosber; Matthias Möhrenschlager; Knut Brockow
Journal:  Chem Immunol Allergy       Date:  2010-06-01

Review 6.  General considerations on rapid desensitization for drug hypersensitivity - a consensus statement.

Authors:  J R Cernadas; K Brockow; A Romano; W Aberer; M J Torres; A Bircher; P Campi; M L Sanz; M Castells; P Demoly; W J Pichler
Journal:  Allergy       Date:  2010-08-17       Impact factor: 13.146

7.  Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis.

Authors:  Yusuke Tsujimura; Kazushige Obata; Kaori Mukai; Hideo Shindou; Masayuki Yoshida; Hideto Nishikado; Yohei Kawano; Yoshiyuki Minegishi; Takao Shimizu; Hajime Karasuyama
Journal:  Immunity       Date:  2008-03-13       Impact factor: 31.745

8.  Peanut and tree nut allergy in childhood.

Authors:  Justin M Skripak; Robert A Wood
Journal:  Pediatr Allergy Immunol       Date:  2008-06       Impact factor: 6.377

9.  Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.

Authors:  Mariana C Castells; Nichole M Tennant; David E Sloane; F Ida Hsu; Nora A Barrett; David I Hong; Tanya M Laidlaw; Henry J Legere; Samridhi N Nallamshetty; Ross I Palis; Jayanti J Rao; Suzanne T Berlin; Susana M Campos; Ursula A Matulonis
Journal:  J Allergy Clin Immunol       Date:  2008-05-27       Impact factor: 10.793

10.  Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice.

Authors:  Adrian M Piliponsky; Ching-Cheng Chen; Michele A Grimbaldeston; Stacy M Burns-Guydish; Jonathan Hardy; Janet Kalesnikoff; Christopher H Contag; Mindy Tsai; Stephen J Galli
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

View more
  29 in total

Review 1.  Evolution of Immune Responses in Food Immunotherapy.

Authors:  Johanna M Smeekens; Michael D Kulis
Journal:  Immunol Allergy Clin North Am       Date:  2019-11-06       Impact factor: 3.479

Review 2.  IgE receptor signaling in food allergy pathogenesis.

Authors:  Hans C Oettgen; Oliver T Burton
Journal:  Curr Opin Immunol       Date:  2015-09-18       Impact factor: 7.486

Review 3.  Immunotherapy in allergy and cellular tests: state of art.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin Immunother       Date:  2014-05-02       Impact factor: 3.452

Review 4.  The immunology of food allergy.

Authors:  Laura K Johnston; Karen B Chien; Paul J Bryce
Journal:  J Immunol       Date:  2014-03-15       Impact factor: 5.422

Review 5.  Immune mechanisms of oral immunotherapy.

Authors:  Michael D Kulis; Sarita U Patil; Erik Wambre; Brian P Vickery
Journal:  J Allergy Clin Immunol       Date:  2017-12-26       Impact factor: 10.793

6.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

Review 7.  Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.

Authors:  Matthieu Picard; Mariana C Castells
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

8.  Global microRNA expression is essential for murine mast cell development in vivo.

Authors:  Sun Young Oh; Stephanie Brandal; Reuben Kapur; Zhou Zhu; Clifford M Takemoto
Journal:  Exp Hematol       Date:  2014-09-06       Impact factor: 3.084

9.  New modalities of allergen immunotherapy.

Authors:  Manish Ramesh; Merhunisa Karagic
Journal:  Hum Vaccin Immunother       Date:  2018-09-14       Impact factor: 3.452

Review 10.  Molecular and cellular mechanisms of food allergy and food tolerance.

Authors:  R Sharon Chinthrajah; Joseph D Hernandez; Scott D Boyd; Stephen J Galli; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2016-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.